Organization and Summary of Significant Accounting Policies (Tables)
|
9 Months Ended |
Sep. 30, 2026 |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] |
|
| Summary of Financial Instruments Measured at Fair Value on Recurring Basis |
The following tables summarize the Company’s financial instruments measured at fair value on a recurring basis (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements at Reporting Date Using |
|
|
|
Total |
|
|
Quoted Prices in Active Markets for Identical Assets (Level 1) |
|
|
Significant Other Observable Inputs (Level 2) |
|
|
Significant Unobservable Inputs (Level 3) |
|
As of September 30, 2026: |
|
|
|
|
|
|
|
|
|
|
|
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
|
$ |
36,217 |
|
|
$ |
36,217 |
|
|
$ |
— |
|
|
$ |
— |
|
Total cash equivalents |
|
|
36,217 |
|
|
|
36,217 |
|
|
|
— |
|
|
|
— |
|
Short-term investments: |
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury securities |
|
|
174,802 |
|
|
|
174,802 |
|
|
|
— |
|
|
|
— |
|
U.S. agency bonds |
|
|
368,249 |
|
|
|
— |
|
|
|
368,249 |
|
|
|
— |
|
Corporate debt securities |
|
|
173,010 |
|
|
|
— |
|
|
|
173,010 |
|
|
|
— |
|
Commercial paper |
|
|
187,838 |
|
|
|
— |
|
|
|
187,838 |
|
|
|
— |
|
Total short-term investments |
|
|
903,899 |
|
|
|
174,802 |
|
|
|
729,097 |
|
|
|
— |
|
Restricted cash: |
|
|
|
|
|
|
|
|
|
|
|
|
Money market account |
|
|
816 |
|
|
|
816 |
|
|
|
— |
|
|
|
— |
|
Total restricted cash |
|
|
816 |
|
|
|
816 |
|
|
|
— |
|
|
|
— |
|
Total assets measured at fair value on a recurring basis |
|
$ |
940,932 |
|
|
$ |
211,835 |
|
|
$ |
729,097 |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements at Reporting Date Using |
|
|
|
Total |
|
|
Quoted Prices in Active Markets for Identical Assets (Level 1) |
|
|
Significant Other Observable Inputs (Level 2) |
|
|
Significant Unobservable Inputs (Level 3) |
|
As of December 31, 2025: |
|
|
|
|
|
|
|
|
|
|
|
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
|
$ |
41,085 |
|
|
$ |
41,085 |
|
|
$ |
— |
|
|
$ |
— |
|
Commercial paper |
|
|
9,478 |
|
|
|
— |
|
|
|
9,478 |
|
|
|
— |
|
Total cash equivalents |
|
|
50,563 |
|
|
|
41,085 |
|
|
|
9,478 |
|
|
|
— |
|
Short-term investments: |
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury securities |
|
|
123,296 |
|
|
|
123,296 |
|
|
|
— |
|
|
|
— |
|
U.S. agency bonds |
|
|
392,008 |
|
|
|
— |
|
|
|
392,008 |
|
|
|
— |
|
Corporate debt securities |
|
|
317,168 |
|
|
|
— |
|
|
|
317,168 |
|
|
|
— |
|
Commercial paper |
|
|
81,761 |
|
|
|
— |
|
|
|
81,761 |
|
|
|
— |
|
Total short-term investments |
|
|
914,233 |
|
|
|
123,296 |
|
|
|
790,937 |
|
|
|
— |
|
Restricted cash: |
|
|
|
|
|
|
|
|
|
|
|
|
Money market account |
|
|
816 |
|
|
|
816 |
|
|
|
— |
|
|
|
— |
|
Total restricted cash |
|
|
816 |
|
|
|
816 |
|
|
|
— |
|
|
|
— |
|
Total assets measured at fair value on a recurring basis |
|
$ |
965,612 |
|
|
$ |
165,197 |
|
|
$ |
800,415 |
|
|
$ |
— |
|
|
| Reconciliation of Cash and Cash Equivalents and Restricted Cash |
The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the accompanying balance sheets that sum to the amounts shown in the condensed statements of cash flows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
September 30, 2026 |
|
|
December 31, 2025 |
|
Cash and cash equivalents |
|
$ |
41,818 |
|
|
$ |
52,334 |
|
Restricted cash |
|
|
816 |
|
|
|
816 |
|
Total cash and cash equivalents and restricted cash |
|
$ |
42,634 |
|
|
$ |
53,150 |
|
|
| Summary of Short-Term Investments |
The following tables summarize short-term investments (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2026 |
|
|
|
Amortized |
|
|
Unrealized |
|
|
Estimated |
|
|
|
Cost |
|
|
Gains |
|
|
Losses |
|
|
Fair Value |
|
U.S. Treasury securities |
|
$ |
177,362 |
|
|
$ |
— |
|
|
$ |
(2,560 |
) |
|
$ |
174,802 |
|
U.S. agency bonds |
|
|
371,372 |
|
|
|
69 |
|
|
|
(3,192 |
) |
|
|
368,249 |
|
Corporate debt securities |
|
|
173,349 |
|
|
|
22 |
|
|
|
(361 |
) |
|
|
173,010 |
|
Commercial paper |
|
|
188,310 |
|
|
|
— |
|
|
|
(472 |
) |
|
|
187,838 |
|
Total |
|
$ |
910,393 |
|
|
$ |
91 |
|
|
$ |
(6,585 |
) |
|
$ |
903,899 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2025 |
|
|
|
Amortized |
|
|
Unrealized |
|
|
Estimated |
|
|
|
Cost |
|
|
Gains |
|
|
Losses |
|
|
Fair Value |
|
U.S. Treasury securities |
|
$ |
123,072 |
|
|
$ |
233 |
|
|
$ |
(9 |
) |
|
$ |
123,296 |
|
U.S. agency bonds |
|
|
389,831 |
|
|
|
2,195 |
|
|
|
(18 |
) |
|
|
392,008 |
|
Corporate debt securities |
|
|
315,294 |
|
|
|
1,874 |
|
|
|
— |
|
|
|
317,168 |
|
Commercial paper |
|
|
81,720 |
|
|
|
47 |
|
|
|
(6 |
) |
|
|
81,761 |
|
Total |
|
$ |
909,917 |
|
|
$ |
4,349 |
|
|
$ |
(33 |
) |
|
$ |
914,233 |
|
|
| Schedule of Contractual Maturities of Available-for-sale Debt Securities |
Contractual maturities of available-for-sale debt securities are as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2026 |
|
|
|
Due in 1 Year or Less |
|
|
Due Between 1 and 3 Years |
|
U.S. Treasury securities |
|
$ |
45,914 |
|
|
$ |
128,888 |
|
U.S. agency bonds |
|
|
192,947 |
|
|
|
175,302 |
|
Corporate debt securities |
|
|
144,286 |
|
|
|
28,724 |
|
Commercial paper |
|
|
187,838 |
|
|
|
— |
|
Total |
|
$ |
570,985 |
|
|
$ |
332,914 |
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2025 |
|
|
|
Due in 1 Year or Less |
|
|
Due Between 1 and 3 Years |
|
U.S. Treasury securities |
|
$ |
40,011 |
|
|
$ |
83,285 |
|
U.S. agency bonds |
|
|
162,804 |
|
|
|
229,204 |
|
Corporate debt securities |
|
|
185,835 |
|
|
|
131,333 |
|
Commercial paper |
|
|
81,761 |
|
|
|
— |
|
Total |
|
$ |
470,411 |
|
|
$ |
443,822 |
|
|
| Summary of Potentially Dilutive Shares Not Included in the Calculation of Net Loss Per Share |
Potentially dilutive securities not included in the calculation of diluted net loss per share, because to do so would be anti-dilutive, are as follows (in common stock equivalent shares):
|
|
|
|
|
|
|
|
|
|
|
As of September 30, |
|
|
|
2026 |
|
|
2025 |
|
Common stock options outstanding |
|
|
9,894,232 |
|
|
|
9,954,999 |
|
Unvested RSUs |
|
|
1,136,514 |
|
|
|
681,171 |
|
Employee stock purchase plan shares |
|
|
36,242 |
|
|
|
28,651 |
|
Total potentially dilutive shares |
|
|
11,066,988 |
|
|
|
10,664,821 |
|
|